136995-29-4Relevant articles and documents
HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS
-
Page/Page column 225, (2010/01/12)
The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the
Inhibitors of IAP
-
Page/Page column 63, (2010/02/15)
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein X, Y, A, R1, R2, R3, R4, R4′, R5, R5′, R6 and R6′ are as described herein.
A general and efficient PIFA mediated synthesis of heterocycle-fused quinolinone derivatives
Herrero, M.Teresa,Tellitu, Imanol,Domínguez, Esther,Hernández, Susana,Moreno, Isabel,SanMartín, Raúl
, p. 8581 - 8589 (2007/10/03)
A new application of the hypervalent iodine reagent phenyliodine(III)bis(trifluoroacetate) (PIFA) has been developed for the construction of a series of N, O, S-containing heterocycle-fused quinolinone derivatives in a general and efficient way. An altern
5-Substituted 4-isoxazolecarboxamides with platelet antiaggregating and other activities
Fossa,Menozzi,Schenone,Filipelli,Russo,Lucarelli,Marmo
, p. 789 - 802 (2007/10/02)
The synthesis of a series of 5-substituted 4-isoxazolecarboxamides by reaction of eight 5-substituted 4-isoxazolecarbonyl chlorides with pyrrolidine, piperidine, morpholine and 4-trifluoromethylaniline is described. Some of these amides showed platelet antiaggregating activity in vitro slightly inferior to that of acetylsalicylic acid, as well weak antiinflammatory, analgesic and antipyretic activities in rats and mice.